NEW YORK (Reuters Health) - Getting a head start on Pfizer's anti-smoking drug Chantix may help smokers kick the habit, according to a preliminary study funded by the company.Full story
NEW YORK (Reuters Health) - When the U.S. Food and Drug Administration announced in 2009 that Pfizer Inc's smoking-cessation drug Chantix would need to carry a restrictive "black box" warning label, the move didn't really surprise the market. Full story
July 1: The FDA on Wednesday warned that anyone taking Chantix and Zyban should be watched closely for signs of mental illness because of a growing number of reports of suicide among patients who take the drugs. NBC's Brian Williams reports.